Meningitis and Later Epilepsy

Meningitis can cause seizures during the acute illness and can also leave brain injury that increases the risk of later epilepsy.

What meningitis affects

Meningitis is inflammation of the membranes surrounding the brain and spinal cord.

Many organisms can cause it, but bacterial meningitis is particularly associated with death and long-term neurological complications.

Acute seizures

Seizures during active meningitis are usually acute symptomatic seizures.

They may result from inflammation, fever, cerebral oedema, infarction, electrolyte disturbance or direct cortical irritation.

Acute seizures do not automatically mean lifelong epilepsy

Some people have seizures only during the infection and never again.

Epilepsy is diagnosed later when recurrent unprovoked seizures develop after the acute disease has resolved.

Who is at greater risk?

Historical and modern literature identifies acute seizures, persistent neurological deficits and significant structural brain injury as important markers of later epilepsy risk.

Pneumococcal meningitis is particularly associated with neurological sequelae.

Stroke and cortical injury

Bacterial meningitis can cause cerebral infarction, vasculitis, cerebritis, abscess, haemorrhage and hydrocephalus.

These structural complications can later form epileptogenic networks.

Long-term sequelae are often missed

A 2026 systematic review of more than 27,000 meningitis cases found that neurological sequelae were frequently detected after hospital discharge, reinforcing the need for structured follow-up.

Reported sequelae included hearing loss, focal neurological deficits, cognitive impairment, developmental problems and seizures.

Children

A 2025 nationwide Danish study found increased long-term neurological morbidity after childhood bacterial meningitis, especially in younger children.

Development, hearing, learning and seizure risk may all require follow-up.

How long should antiseizure treatment continue after acute meningitis?

There is no universal duration.

A 2026 systematic review specifically looked for evidence comparing shorter and longer antiseizure treatment after meningitis-related acute symptomatic seizures and found no direct comparative evidence.

This means treatment duration must be individualised rather than based on a single evidence-backed cut-off.

Vaccination prevents part of this epilepsy burden

Vaccines against pneumococcus, meningococcus and Haemophilus influenzae type b prevent important causes of bacterial meningitis.

The central point

A seizure during meningitis and epilepsy after meningitis are not the same diagnosis. Later epilepsy reflects an enduring epileptogenic consequence of the infection or its complications.

Sources

Evidence checked: September 2026.

Page information · Published:

19 September 2026

If revised after publication, the update date appears below: